Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Seizures 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 19Cyclophosphamide 18venetoclax 15fludarabine phosphate 14Busulfan 14Cyclosporine 12Azacitidine 11fludarabine 10Peripheral Blood Stem Cell Transplantation 10Granulocyte Colony-Stimulating Factor 10Mycophenolic Acid 9Filgrastim 9Melphalan 8Antilymphocyte Serum 8Whole-Body Irradiation 7Palliative Care 7Idarubicin 6Blood Specimen Collection 6Methotrexate 5Therapeutics 4Specimen Handling 4Radiotherapy 4Methods 4Early Intervention, Educational 4Daunorubicin 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Tacrolimus 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myeloid, Acute × Levetiracetam × Clear all
NCT01685411 2021-04-13

Busulfan and Cyclophosphamide Followed By ALLO BMT

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
5 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡